Metropolis Opens Centre of Genomics to Boost Precision Diagnostics

Metropolis Healthcare, India’s second-largest pathology chain, has launched its Centre of Genomics, a major step in expanding its advanced genomics, molecular diagnostics, and precision medicine capabilities. The centre is designed to deliver clinically actionable genomic insights across multiple high-impact clinical specialties, supporting personalised patient care.

The Centre integrates Metropolis’s existing sequencing infrastructure with Illumina’s NovaSeq X Series, featuring XLEAP-SBS chemistry, which can generate over 20,000 whole genomes annually. Alongside its multi-platform NGS infrastructure, the centre brings together molecular pathologists, genomic scientists, bioinformaticians, and certified genetic counsellors to translate complex genomic data into reliable clinical insights.

Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare, said, “Genomics marks a decisive inflection point for diagnostics in India, expanding the role of laboratories from disease detection to risk prediction, therapy personalization, and long-term disease management. As genomics increasingly informs lifelong medical decisions, leadership in this space is defined not by adoption alone, but by rigorous validation, deep expertise, quality assurance, and clinical responsibility. Through the Centre of Genomics, we bring together orthogonal, cross-platform technologies with advanced data analytics and AI-driven trend correlations.”

Dr. Kirti Chadha, chief scientific and innovation officer, said, “With over 220 validated genomic tests and a clear roadmap to expand beyond 500 assays over the next two to three years, the Centre of Genomics is benchmarked against leading global genomic laboratories.” Illumina’s Suchita Dayanand added, “The NovaSeq X Series demonstrates our leadership in next-generation sequencing, and we are proud to see Metropolis Healthcare leveraging our most sustainable high-throughput sequencer to drive transformative research and innovation.”

The Centre of Genomics positions Metropolis at the forefront of precision diagnostics in India, combining cutting-edge technology, clinical expertise, and AI-driven analytics for comprehensive genomic care.